-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NPxJfse9QqCz5Sk80waoXoFCVIjfJGGZCxtopZaSnt+JRhcp2pd7DwErPZ/FQAgw GxyAa2AOGRszoCwMC8bsDQ== 0001498376-10-000003.txt : 20101102 0001498376-10-000003.hdr.sgml : 20101102 20101102140947 ACCESSION NUMBER: 0001498376-10-000003 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20101001 FILED AS OF DATE: 20101102 DATE AS OF CHANGE: 20101102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Babiss Lee CENTRAL INDEX KEY: 0001498376 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27570 FILM NUMBER: 101157564 MAIL ADDRESS: STREET 1: 3201 CARNEGIE AVENUE CITY: CLEVELAND STATE: OH ZIP: 44115 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACEUTICAL PRODUCT DEVELOPMENT INC CENTRAL INDEX KEY: 0001003124 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 561640186 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 BUSINESS PHONE: 9102510081 MAIL ADDRESS: STREET 1: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 3 1 primary_doc.xml PRIMARY DOCUMENT X0203 3 2010-10-01 0 0001003124 PHARMACEUTICAL PRODUCT DEVELOPMENT INC PPDI 0001498376 Babiss Lee 929 NORTH FRONT STREET WILMINGTON NC 28401 0 1 0 0 Exec. VP - Global Lab Services Stock Options (to buy) 20.45 2011-02-25 2020-02-25 Common Stock 46578 D Stock Options (to buy) 26.64 2011-06-17 2020-06-17 Common Stock 15000 D These options vest in three equal increments on 2/25/11, 2/25/12 and 2/25/13. These options vest in three equal increments on 6/17/11, 6/17/12 and 6/17/13. Lisa C. Noecker attorney-in-fact for Lee E. Babiss 2010-11-02 EX-24 2 poababiss.txt POA POWER OF ATTORNEY Know all by these presents that the undersigned hereby constitutes and appoints each of Fredric N. Eshelman, B. Judd Hartman, June Knott and Lisa Noecker, and each of them acting alone, signing singly, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer of Pharmaceutical Product Development, Inc. (the "Company"), Forms ID, 3, 4 and 5 (and any amendments thereto) under Section 16(a) of the Securities Exchange Act of 1934, as amended (the "1934 Act") in accordance with the 1934 Act, and the rules promulgated thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form ID, 3, 4, or 5 (and any amendments thereto)and to file timely such Forms with the United States Securities and Exchange Commission and any stock exchange or Similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in- fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in- Fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney- in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16(a) of the 1934 Act. This Power of Attorney is governed by and shall be Construed in accordance with the laws of the State of North Carolina. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file such Forms with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned, which revocation shall be evidenced in writing. This Power of Attorney is executed pursuant to the provisions of the North Carolina General Statutes, Chapter 32A, Article 2, with the intention that this Power of Attorney and the authority of said attorney-in-fact hereunder shall continue in effect notwithstanding any incapacity or mental incompetence which may be incurred by the undersigned subsequent to the execution of this Power of Attorney by the undersigned. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 29th day of October 2010. /s/ Lee E. Babiss Lee E. Babiss -----END PRIVACY-ENHANCED MESSAGE-----